Home
RTW Investments reported a 4.8% stake in Spyre Therapeutics SYRE · 4,251,996 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.8%
- Last report
- 6.2% · filed 25/02/14
- Shares held
- 4,251,996 sh
- Class
- Common Stock, $0.0001 par value
- Holder
- RTW Investments
- Event date
- 26/06/30
- Filed
- 26/08/14
4.8% stake · below 5%
- Stake
- 4.8%
- Last report
- 6.2%
- Since last report
- −1.4pp
Spyre Therapeutics trades, last 26 weeks
What else happened in Spyre Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30RTW Investments's other 5% stake reports
- RTW Investments
5% stakeAllurion Technologies
5% stakeAllurion Technologies
ALUR
9.9% stake
67,441 sh
9.9% stake
Filed 09/02
- RTW Investments
5% stakeuniQure
5% stakeuniQure
QURE
5.7% stake
3,941,572 sh
5.7% stake
Filed 08/14
- RTW Investments
5% stakeUltragenyx Pharmaceutical
5% stakeUltragenyx Pharmaceutical
RARE
7.9% stake
7,796,895 sh
7.9% stake
Filed 08/14
- RTW Investments
5% stakeRadNet
5% stakeRadNet
RDNT
6.2% stake
4,846,958 sh
6.2% stake
Filed 08/14
- RTW Investments
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
5.2% stake
3,139,030 sh
5.2% stake
Filed 08/14
